Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Total Liabilities
Everything the company owes to creditors and other parties.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Total Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total liabilities rises 51.7% from a year ago
Total liabilities stood at $205.8M at the end of Q2 FY2026, up 51.7% from a year earlier and up 24.5% from the prior quarter. Over 3 fiscal years it compounded at -17.3% a year.
Context
- Total liabilities amounted to 10.7% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Total liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +51.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 168.19M USD
- Year-over-year change
- +87.5%
- 3-year CAGR
- -17.3%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 168.19M | +87.5% |
| FY2024 | 2024-12-31 | 89.71M | +130.8% |
| FY2023 | 2023-12-31 | 38.87M | -86.9% |
| FY2022 | 2022-12-31 | 297.02M | — |
Total Liabilities vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's Jun 2026 total liabilities of $205.8M is the lowest of the 7 companies compared; the peer median is $10.85B.
- Its year-over-year change of +51.7% is the 2nd highest of 7, against a peer median of +8.5%.
- Total liabilities amounts to 10.7% of total assets for ALAB, versus a peer median of 37.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $17.65B | -3.9% | +13.2% | 47.9% | |
| Aug 2026 | $14.87B | +5.4% | +0.8% | 30.7% | |
| Jun 2026 | $12.68B | +2.7% | +7.7% | 48.6% | |
| Aug 2026 | $9.02B | +25.9% | +5.0% | 32.7% | |
| Sep 2026 | $383.42M | +11.7% | -12.2% | 41.8% | |
| Aug 2026 | $284.24M | +129.6% | +67.2% | 9.4% | |
| Jun 2026 | $205.8M | +51.7% | -17.3% | 10.7% | |
| Peer median (excluding ALAB) | $10.85B | +8.5% | +6.4% | 37.3% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.